What SelectBio does

SelectBio, operating under the legal entity Select Biosciences, is a Vancouver, USA-based private conference and exhibition organizer focused exclusively on the life sciences sector. The company was founded in 1999 and operates with a headcount of 11-50 employees, generating revenue primarily through delegate registration fees and exhibitor/sponsorship packages for its portfolio of scientific conferences. SelectBio does not develop scientific instruments or reagents itself; rather, its product is the convening of researchers, academic scientists, and life science technology companies around narrow scientific topics where generalist conferences would dilute attendee relevance.

The company's product portfolio for 2026 comprises 15+ scheduled conferences spanning microfluidics and lab-on-a-chip, extracellular vesicles (EVs) and exosomes, lipid nanoparticles (LNPs), point-of-care and rapid diagnostics, flow chemistry, and space biotechnology. Events are held across North America (Portland, Denver, Laguna Hills), Europe (Montpellier, France), and Asia-Pacific (Shenzhen, Tokyo-Narita, Kuala Lumpur). SelectBio also offers registration support services and email-based delegate and exhibitor engagement, and introduced a webinars/virtual events channel in 2026 to complement in-person programming. Underlying technology consists of a conference and exhibition management platform supporting delegate registration, event logistics, and direct email outreach; no proprietary AI/ML, data products, or software APIs are offered.

SelectBio's go-to-market is event-driven: the company markets each conference through its corporate website and a delegate email database, leveraging long-standing relationships within specialized scientific communities. Customer segments split between persona-based individual attendees (life science researchers and academics) and business-based sponsors/exhibitors (life science technology companies commercializing instruments, EV analysis tools, LNP delivery systems, and diagnostics). Pricing is not publicly disclosed and is quote-based per conference and delegate type, with registration support managed via a single email channel. The company appears to be independently held with no disclosed institutional investors, parent company, or PE/VC backing, consistent with a cash-generative small business serving a stable, recurring niche.

Name

SelectBio

Legal name

Select Biosciences

Website

https://selectbiosciences.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

SelectBio is a privately held Vancouver, USA-based organizer of niche life science conferences and exhibitions, serving academic researchers and life science technology companies across microfluidics, extracellular vesicles, lipid nanoparticles, diagnostics, and related biomedical verticals through 15+ annual global events.

Ownership category

akta.pro rank

Headquarters

HQ city

Vancouver

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Conference Registration and Exhibition Fees: SelectBIO generates revenue through delegate registration fees for conference attendance and exhibition/sponsorship packages for companies showcasing products and services at their life science conferences. The company organizes 15+ conferences annually across multiple global locations.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

SelectBio organizes and hosts 15+ scientific conferences and exhibitions annually in highly specialized life science domains including microfluidics, lab-on-a-chip, extracellular vesicles (EVs), lipid nanoparticles (LNPs), point-of-care diagnostics, flow chemistry, and space biotechnology. The company delivers these events across global venues in North America, Europe, and Asia-Pacific, generating revenue through delegate registration fees and corporate exhibition/sponsorship packages.

Product overview

SelectBio is a life science conferences company that organizes a portfolio of scientific conferences and exhibitions focused on microfluidics, lab-on-a-chip technologies, extracellular vesicles (EVs), exosomes, lipid nanoparticles (LNPs), point-of-care diagnostics, flow chemistry, and space biotechnology. The company's offering consists of individual conference events organized by topic and geographic region, spanning North America (Portland, Denver, Laguna Hills), Europe (Montpellier), and Asia-Pacific (Shenzhen, Tokyo-Narita, Kuala Lumpur). Each conference serves as a venue for scientific exchange, featuring topics such as EV cargo analysis tools, next-generation instruments, biomarkers, diagnostics, wearable technologies, and 3D-printing applications. The portfolio includes 15 scheduled conferences for 2026, with some events combining related topics (e.g., Microfluidics, EVs & LNPs Europe; EVs & LNPs Laguna Hills).

Differentiator

Problem solved

Functional benefit

Products and services

• Microfluidics for Biomedical Innovation 2026 A two-day conference focused on microfluidics technologies for biomedical applications, held in Shenzhen, China in January 2026. Targeted at scientists, researchers, and life science technology companies working in microfluidics and lab-on-a-chip.
• Extracellular Vesicles 2026: Tools, Biomarkers & Diagnostics A two-day conference covering extracellular vesicles tools, biomarkers, and diagnostic applications, held in Shenzhen, China in January 2026. For researchers and technology vendors in EV/exosome science and diagnostics.
• Extracellular Vesicle (EV) Cargo and Functional Analysis Tools 2026 A conference focused on EV cargo analysis and functional analysis tools, held in Portland, Oregon in March 2026. For researchers and tool providers in extracellular vesicle analytical methods.
• Next-Gen Instruments & Tools Driving EV Research 2026 Conference showcasing next-generation instruments and tools for extracellular vesicle research, held in Denver, Colorado in March 2026. Targets instrument vendors and EV researchers.
• Flow Chemistry Asia 2026 A two-day conference on flow chemistry and API synthesis, held in Shenzhen, China in June 2026. For researchers and technology providers in flow chemistry and chemical synthesis.
• Innovations in Microfluidics, Extracellular Vesicles & Lipid Nanoparticles Europe 2026 Combined conference on microfluidics, EVs, and LNPs innovations, held in Montpellier, France in September 2026. Targets European researchers and technology vendors across the three intersecting verticals.
• Microfluidics, 3D-Printing, Point-of-Care-Rapid Diagnostics Japan 2026 Conference covering microfluidics, 3D-printing technologies, and rapid diagnostics, held in Tokyo-Narita, Japan in October 2026. For researchers and vendors in diagnostics and 3D bioprinting.
• Lipid Nanoparticles (LNPs) Asia/Pacific 2026 Conference focused on lipid nanoparticle research and applications in the Asia-Pacific region, held in Tokyo-Narita, Japan in October 2026. Targets researchers and technology providers in LNP delivery systems.
• Extracellular Vesicles (EV) Asia/Pacific-Japan 2026 Asia/Pacific-focused conference on extracellular vesicles research, held in Tokyo-Narita, Japan in October 2026. For EV researchers and vendors in the region.
• Space Summit Asia-Pacific 2026 Space Summit conference covering space biotechnology and life sciences applications in the Asia-Pacific region, held in Tokyo-Narita, Japan in October 2026. Targets researchers and companies in space biotech and life sciences.
• Lab-on-a-Chip & Microfluidics World Congress 2026 World congress on lab-on-a-chip technologies and microfluidics, held in Laguna Hills, California in October 2026. For the global microfluidics research and technology community.
• Extracellular Vesicles (EVs) & Lipid Nanoparticles (LNPs) 2026 Combined conference on extracellular vesicles and lipid nanoparticles research, held in Laguna Hills, California in October 2026. Targets researchers and vendors across both EVs and LNPs verticals.
• Space Summit West 2026 Space Summit covering western region space biotechnology topics, held in Laguna Hills, California in October 2026. Targets researchers and companies in space biotech and life sciences.
• Extracellular Vesicles Asia 2026: Tools to Dx and Rx Conference focused on extracellular vesicle tools for diagnostics and therapeutics in Asia, held in Kuala Lumpur, Malaysia in December 2026. For EV researchers and diagnostic/therapeutic technology vendors.
• Point-of-Care, Rapid Diagnostics & Biosensors 2026 Conference on point-of-care diagnostics, rapid testing, and biosensor technologies, held in Kuala Lumpur, Malaysia in December 2026. For diagnostics researchers and rapid test/biosensor technology vendors.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Cambridge Healthtech Institute (CHI): A direct competitor organizing niche life science conferences across biologics, diagnostics, and drug discovery. Highly comparable in targeting research-driven audiences with multi-topic specialized events.
• Hanson Wade: Specialist life science conference organizer with deep coverage of biopharma R&D, biomarkers, and translational research. Closely comparable niche-led event business model.
• Oxford Global: Organizes specialized life science and biomedical conferences in areas including biologics, NGS, and drug discovery. Comparable in focusing on narrow R&D verticals with academic/industry audiences.

Broad incumbents

• Informa (Life Sciences division): Global events giant with a sizable life science portfolio. Competes in adjacent conference verticals with significantly larger scale, brand, and sponsor relationships.
• Reed Exhibitions: Large incumbent organizer of B2B exhibitions and conferences, including life science adjacent events. Broader portfolio and deeper resources create competitive pressure.
• Elsevier (Events): Scientific publisher that runs life science conferences and uses its journal brand and author networks to attract delegates. Comparable in serving biomedical research communities.

Emerging players

• SLAS (Society for Laboratory Automation and Screening): Membership organization running conferences on lab automation, screening, and microfluidics-adjacent topics. Overlaps with SelectBio's lab-on-a-chip and screening audiences.
• CHI Health Bio (Bio-IT World conferences): Operates conferences serving life science informatics, diagnostics, and translational research communities, partially overlapping SelectBio's diagnostics and tools audiences.

Others

• Fierce Biotech / Fierce Pharma (Events): Life science media brand that runs conferences and events. Comparable audience reach in biotech but operates more as a media/events hybrid than a pure conference promoter.
• BioCentury: Biotech industry information and events business. Serves overlapping executive and investor audiences in life sciences with adjacent conferences and editorial products.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/with_replies
• Facebookfacebook.com/selectbioconferences
• LinkedInlinkedin.com/company/select-biosciences

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SelectBio